Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib(® )versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation – HeiLivCa [ISRCTN24081794]

BACKGROUND: Disease progression of hepatocellular cancer (HCC) in patients eligible for liver transplantation (LTx) occurs in up to 50% of patients, resulting in withdrawal from the LTx waiting list. Transarterial chemoembolization (TACE) is used as bridging therapy with highly variable response rat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hoffmann, K, Glimm, H, Radeleff, B, Richter, G, Heining, C, Schenkel, I, Zahlten-Hinguranage, A, Schirrmacher, P, Schmidt, J, Büchler, MW, Jaeger, D, von Kalle, C, Schemmer, P
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2008
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2630329/
https://ncbi.nlm.nih.gov/pubmed/19036146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-8-349
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados